Recent Finacing
Recent Raise
Sequrna develops and markets a synthetic, thermostable, non-protein RNase inhibitor that ships and stores at room temperature, designed for single-cell transcriptomics, RNA-sequencing, and mRNA manufacturing workflows.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Sequrna.
